Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
5.59
+0.16 (2.95%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $726.61 million as of October 23, 2026. It is the 12,061st most valuable company in the world and the 2,447th biggest in the United States. Its market cap has increased by 38.96% in one year.
Market Cap
726.61M
Enterprise Value
491.06M
1-Year Change
38.96%
Global Rank
Country Rank
#2,447 United States
Category
ChartMarket Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $726.61M, a decrease of -67.86%. That is a compound annual growth rate of -19.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 726.61M | 12.53% |
| Dec 31, 2025 | 645.72M | -22.76% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
| Jul 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| QuidelOrtho | 961.43M |
| Beta Bionics | 954.92M |
| SI-BONE | 936.93M |
| Integra LifeSciences Holdings | 905.27M |
| AdaptHealth | 807.13M |
| InMode | 803.87M |
| Varex Imaging | 776.36M |
| Pacific Biosciences of California | 657.41M |